Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease
Recruiting
Observational Study
Interstitial Lung Disease (ILD)
Idiopathic Pulmonary Fibrosis (IPF)
Progressive Pulmonary Fibrosis
Connective Tissue Disease-Associated Interstitial Lung Disease
Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Hospital de Granollers · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The OXISITE-ILD study is a prospective, multicenter, observational study designed to evaluate the agreement between finger (digital) and earlobe (auricular) pulse oximetry for measuring oxygen saturation (SpO2) during the six-minute walk test (6MWT) in patients with interstitial lung disease (ILD). In routine clinical practice, exercise SpO2 is usually measured at the finger; however, the finger r…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 years or older
* Confirmed diagnosis of interstitial lung disease (ILD) based on clinical, radiological and/or histological criteria
* Newly diagnosed or under follow-up for ILD
* Physically and cognitively able to perform the 6-minute walk test (6MWT)
* Signed …
Contacts